Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The activin type II-B receptor (ACVR2B) is a transmembrane serine/threonine kinase receptor belonging to the TGF-β superfamily. It mediates signals from TGF-β family ligands, including activins and myostatin, playing a central role in regulating muscle mass and other biological processes such as cell growth, differentiation, apoptosis, homeostasis, osteogenesis, fibrosis regulation, inflammation control, and neurogenesis modulation.
Blocking myostatin signaling pathway to stimulate muscle hypertrophy or regeneration
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Activin Type II-B Receptor (ACVR2B).